Topical Minoxidil（5%） to the scalp. — Competitive Intelligence Brief

Topical Minoxidil（5%） to the scalp. (Topical Minoxidil（5%） to the scalp.) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Potassium channel opener / topical vasodilator. Area: Dermatology.

marketed Potassium channel opener / topical vasodilator ATP-sensitive potassium channels Dermatology Small molecule

Target snapshot

Topical Minoxidil（5%） to the scalp. (Topical Minoxidil（5%） to the scalp.) — Southern Medical University, China. Minoxidil is a potassium channel opener that increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Topical Minoxidil（5%） to the scalp. TARGET	Topical Minoxidil（5%） to the scalp.	Southern Medical University, China	marketed	Potassium channel opener / topical vasodilator	ATP-sensitive potassium channels
metformin/glimepiride combination	metformin/glimepiride combination	Laboratorios Silanes S.A. de C.V.	marketed	Biguanide/Sulfonylurea combination	AMP-activated protein kinase (AMPK) pathway; ATP-sensitive potassium channels (KATP)
metformin+ gliclazide	metformin+ gliclazide	GlaxoSmithKline	marketed	Antidiabetic combination (biguanide + sulfonylurea)	Metformin: mitochondrial glycerophosphate dehydrogenase; Gliclazide: ATP-sensitive potassium channels on pancreatic beta cells
metformin, glyburide and glargine	metformin, glyburide and glargine	The University of Texas Health Science Center at San Antonio	marketed	Combination antidiabetic therapy (biguanide + sulfonylurea + basal insulin)	Multiple: AMP-activated protein kinase (metformin), ATP-sensitive potassium channels (glyburide), insulin receptor (glargine)
Levosimendan Injection	Levosimendan Injection	Peking University Third Hospital	marketed	Calcium sensitizer / inotropic agent	Cardiac troponin C; ATP-sensitive potassium channels
Levosimendan infusion	Levosimendan infusion	AHEPA University Hospital	marketed	Calcium sensitizer / inodilator	Cardiac troponin C; ATP-sensitive potassium channels
Minoxidil Topical	Minoxidil Topical	Dr. dr. Lili Legiawati, SpKK(K)	marketed	Potassium channel opener	ATP-sensitive potassium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Potassium channel opener / topical vasodilator class)

1. Southern Medical University, China · 1 drug in this class